Helus Pharma, Inc. (HELP)
10.60
-0.12
(-1.07%)
USD |
NASDAQ |
Oct 30, 16:00
10.72
+0.12
(+1.18%)
After-Hours: 20:00
Helus Pharma Shareholders Equity (Quarterly) : 242.09M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 242.09M |
| March 31, 2026 | 231.79M |
| December 31, 2025 | 273.93M |
| September 30, 2025 | 139.00M |
| June 30, 2025 | 151.76M |
| March 31, 2025 | 164.81M |
| December 31, 2024 | 167.04M |
| September 30, 2024 | 188.77M |
| June 30, 2024 | 204.50M |
| March 31, 2024 | 215.72M |
| December 31, 2023 | 91.93M |
| September 30, 2023 | 35.79M |
| June 30, 2023 | 30.00M |
| March 31, 2023 | 35.64M |
| December 31, 2022 | 41.57M |
| September 30, 2022 | 46.75M |
| June 30, 2022 | 52.86M |
| Date | Value |
|---|---|
| March 31, 2022 | 60.97M |
| December 31, 2021 | 70.53M |
| September 30, 2021 | 78.46M |
| June 30, 2021 | 61.59M |
| March 31, 2021 | 68.52M |
| December 31, 2020 | 41.50M |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | 0.3006M |
| April 30, 2019 | 0.3088M |
| January 31, 2019 | 0.3067M |
| October 31, 2018 | 0.3146M |
| July 31, 2018 | 0.3381M |
| April 30, 2018 | 0.3916M |
| January 31, 2018 | 0.4163M |
| October 31, 2017 | 0.2233M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 1.075M |
| NervGen Pharma Corp. | 33.02M |
| Milestone Pharmaceuticals, Inc. | 18.22M |
| Appili Therapeutics, Inc. | -13.41M |
| Clearmind Medicine, Inc. | 12.95M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 259.66M |
| Total Liabilities (Quarterly) | 17.57M |
| Current Ratio | 10.97 |